Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > Á¦¾àȸ»çºÐ¼® > U.S. CRO Markets - Key Therapeutic Areas
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4931)
°¨¿°Áúȯ (349)
°ñÁúȯ Ä¡·á (38)
´ç´¢º´ (194)
¹é½Å (181)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (44)
ºñó¹æ ÀǾàǰ (152)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (174)
½Å¾à°³¹ß (1529)
¾ÏÄ¡·á (941)
¾à¹°Àü´Þ (185)
ÀǾàǰ ±ÔÁ¦È¯°æ (127)
Á¤½ÅÁúȯ (86)
Á¦³×¸¯ ÀǾàǰ (128)
Á¦¾àȸ»çºÐ¼® (523)
󹿾à (165)
½ÃÀ庸°í¼­

U.S. CRO Markets - Key Therapeutic Areas

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2009³â 07¿ù »óǰÄÚµå 94650
ÆäÀÌÁö Á¤º¸ 71 Pages
°¡°Ý
US $ 6,000 £Ü 7,149,000 Web Access (Regional License)
US $ 6,500 £Ü 7,744,700 Hard Copy & Web Access (Regional License)


¿µ¹®¸ñÂ÷

Abstract

This research service provides a detailed overview and analysis of key therapeutic areas in the U.S. CRO Market. The research service includes a detailed analysis of market trends, industry challenges and key therapeutic areas. Revenue forecasts from 2010 to 2016 have also been included in this research service.

Table of Contents

1. EXECUTIVE SUMMARY

  • Executive Summary
    • 1. Introduction

2. MARKET INTRODUCTION

  • Research Scope and Methodology
    • 1. Scope and Segmentation
    • 2. Research Methodology
  • Market Overview
    • 1. Introduction
    • 2. Measurements
    • 3. Industry Challenges

3. MARKET ANALYSIS

  • Market Forecasts and Trends
    • 1. Market Forecasts
    • 2. Therapeutic Pipeline
  • Revenue Forecasts by Key Therapeutic Markets
    • 1. Oncology
    • 2. Infectious Diseases
    • 3. Central Nervous System
    • 4. Cardiovascular
    • 5. Metabolic Diseases
    • 6. Respiratory and Allergy
    • 7. Others

4. APPENDIX

  • Decision Support Databases
    • 1. Number of Biotech Companies
    • 2. Number of Physicians
    • 3. Private Healthcare Expenditure
    • 4. Total Healthcare Expenditure
    • 5. Total Population
Back to Top